Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Centre for Mendelian Genomics, |
RCV000001551 | SCV000492655 | pathogenic | Acute intermittent porphyria | 2015-11-25 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001389642 | SCV001591075 | pathogenic | not provided | 2023-09-29 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg149*) in the HMBS gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in HMBS are known to be pathogenic (PMID: 7757070, 7962538). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individuals with acute intermittent porphyria (PMID: 7757070, 25118551, 27507172). ClinVar contains an entry for this variant (Variation ID: 1486). For these reasons, this variant has been classified as Pathogenic. |
OMIM | RCV000001551 | SCV000021706 | pathogenic | Acute intermittent porphyria | 2006-01-01 | no assertion criteria provided | literature only | |
Prevention |
RCV003924793 | SCV004737463 | pathogenic | HMBS-related disorder | 2023-11-21 | no assertion criteria provided | clinical testing | The HMBS c.445C>T variant is predicted to result in premature protein termination (p.Arg149*). This variant was reported in individuals with acute intermittent porphyria phenotypes (Table 1, Kauppinen et al. 1995. PubMed ID: 7757070; Ribeiro et al. 2002. PubMed ID: 12357456). This variant has not been reported in a large population database, indicating this variant is rare. Nonsense variants in HMBS are expected to be pathogenic. This variant is interpreted as pathogenic. |